This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Abbott Laboratories Corporation. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Helen Zhu - Innovator in Thiazole Chemistry
Introduction
Helen Zhu is a prominent inventor based in South Bend, IN (US). She has made significant contributions to the field of chemistry, particularly in the development of substituted thiazoles. Her work has implications for the treatment of gout and hyperuricemia, showcasing her dedication to advancing medical science.
Latest Patents
Helen Zhu holds a patent for a process related to substituted thiazoles. Her patent, which includes the compound ethyl 2-(4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylate, also known as TEI-6720, is particularly noteworthy. This compound is recognized for its ability to inhibit xanthine oxidase, thereby blocking uric acid production, which is crucial for treating conditions like gout.
Career Highlights
Throughout her career, Helen has worked with notable companies such as Abbott Laboratories Corporation and AbbVie Inc. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Helen Zhu has collaborated with Timothy A. Robbins, enhancing her research and development efforts. Their partnership has been instrumental in advancing the understanding and application of thiazole compounds.
Conclusion
Helen Zhu's innovative work in thiazole chemistry exemplifies her commitment to improving healthcare solutions. Her contributions continue to impact the medical field positively, particularly in the treatment of gout and hyperuricemia.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile